Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Time | Event | Token | SOL | Actor | Signature |
|---|---|---|---|---|---|
| Other | — | — | Bq1p…tMLu | 4qjQvz…VyKPng | |
| Other | — | — | GHig…BhUc | 2vECTj…umN3FL | |
| Other | — | — | GHig…BhUc | W6JwrG…s3U7ng | |
| Other | — | — | Bq1p…tMLu | 32iCFD…LB3NTY | |
| Other | — | — | Bq1p…tMLu | 2G5SLT…8Fw74S | |
| Other | — | — | FHpc…7wCT | 2orygx…jtkPVw | |
| Other | — | — | BULL…pPFk | 4vySUE…kZsdnW | |
| Other | — | — | BULL…pPFk | 3bsLc4…fhiVGD | |
| Other | — | — | BULL…pPFk | 2xtRtD…KiYtx2 | |
| Other | — | — | BULL…pPFk | xM95wB…2mTnwE | |
| Other | — | — | BULL…pPFk | 3SFv8e…KcK9d8 | |
| Other | — | — | BULL…pPFk | 5c883u…hS4h4s | |
| Other | — | — | BULL…pPFk | 4F7WKP…wykUKq | |
| Other | — | — | GHig…BhUc | 5USdiA…6HyVMh | |
| Other | — | — | GHig…BhUc | 2PE79A…7Q2GXC | |
| Other | — | — | 3zdX…MPL8 | 4gJZ2a…PogDiP | |
| Other | — | — | GHig…BhUc | 2CMqiJ…rHbyge | |
| Other | — | — | GHig…BhUc | 3xajMV…GkMmvb | |
| Other | — | — | GHig…BhUc | 2jdDGU…Cw8dGs | |
| Other | — | — | E3yE…f6tu | 39TyRj…z27aPA |